CA2638081C - Procedes de preparation et d'utilisation de compositions chelatees de citrate de pyrophosphate ferrique - Google Patents

Procedes de preparation et d'utilisation de compositions chelatees de citrate de pyrophosphate ferrique Download PDF

Info

Publication number
CA2638081C
CA2638081C CA2638081A CA2638081A CA2638081C CA 2638081 C CA2638081 C CA 2638081C CA 2638081 A CA2638081 A CA 2638081A CA 2638081 A CA2638081 A CA 2638081A CA 2638081 C CA2638081 C CA 2638081C
Authority
CA
Canada
Prior art keywords
pyrophosphate
ferric
citrate
ion source
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2638081A
Other languages
English (en)
Other versions
CA2638081A1 (fr
Inventor
Jr. Mccall William S.
Original Assignee
Rockwell Medical Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/138,018 external-priority patent/US7816404B2/en
Application filed by Rockwell Medical Technologies Inc filed Critical Rockwell Medical Technologies Inc
Publication of CA2638081A1 publication Critical patent/CA2638081A1/fr
Application granted granted Critical
Publication of CA2638081C publication Critical patent/CA2638081C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Chélate de citrate de pyrophosphate ferrique hautement soluble dans l'eau utile pour le traitement des déficiences en fer renfermant 2 % ou moins de phosphate en poids. Ces chélates peuvent être facilement broyés ou transformés en formes pharmaceutiques à l'aide de techniques classiques, et devraient posséder une biocompatibilité avantageuse par rapport aux pyrophosphates ferriques, aux sels ferriques, aux complexes de polysaccharide ferrique et aux sels ferreux solubles classiques.
CA2638081A 2007-07-20 2008-07-17 Procedes de preparation et d'utilisation de compositions chelatees de citrate de pyrophosphate ferrique Active CA2638081C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US96132707P 2007-07-20 2007-07-20
US60/961,327 2007-07-20
US12/138,018 2008-06-12
US12/138,018 US7816404B2 (en) 2007-07-20 2008-06-12 Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions

Publications (2)

Publication Number Publication Date
CA2638081A1 CA2638081A1 (fr) 2009-01-20
CA2638081C true CA2638081C (fr) 2012-07-10

Family

ID=40265353

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2638081A Active CA2638081C (fr) 2007-07-20 2008-07-17 Procedes de preparation et d'utilisation de compositions chelatees de citrate de pyrophosphate ferrique

Country Status (1)

Country Link
CA (1) CA2638081C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2017009757A0 (en) * 2014-09-08 2017-02-28 Unilever Plc Iron-fortified edible oil-and-water emulsion

Also Published As

Publication number Publication date
CA2638081A1 (fr) 2009-01-20

Similar Documents

Publication Publication Date Title
US7816404B2 (en) Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
US8178709B2 (en) Iron preparation suitable for pharmaceutical formulation and process for the preparation thereof
US20210299168A1 (en) Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
TWI388330B (zh) 鐵-碳水化合物之錯化合物
US9757416B2 (en) Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
WO2008042218A1 (fr) Préparation comprenant un complexe de résine échangeuse d'ions minéraux
IL199901A (en) Ligand Adapted to Oxo-Hydroxy Poly ions Metal Materials, Their Use and Processes for their Preparation
EP2065045B1 (fr) Anti-oxydant destiné à la prévention et au traitement de maladies liées au stress oxydatif
CA2638081C (fr) Procedes de preparation et d'utilisation de compositions chelatees de citrate de pyrophosphate ferrique
US20180256640A1 (en) Magnesium-containing products and uses thereof
AU2016315877B2 (en) Solid soluble ferric pyrophosphate formulations, kits, and methods using the same
JP2009526086A (ja) 燐酸過剰血による病気を治療する薬物及びその製造方法
RU2161963C2 (ru) Фумаратгидрат трехвалентного железа в качестве средства для лечения железодефицитной анемии и фармацевтическая композиция на его основе
CN1191371C (zh) 易被体内吸收的蛋白化铁的制备方法以及利用它生产的保健食品
JPH0586932B2 (fr)
EP0650725A1 (fr) Compositions comprenant des sels de l'acide L-2-oxothiazolidine-4-carboxylique et leur utilisation pour stimuler la glutathione intracellulaire
EP3436441B1 (fr) Procédés de production de compositions de maltol ferrique à partir de fer élémentaire
CN113940342A (zh) 一种包含环糊精衍生物的百草枯组合物及其对哺乳动物减毒的应用
WO2008115915A2 (fr) Sels de l-carnitine non hygroscopiques
CN108264546A (zh) 琥珀酰酪蛋白-亚铁及其制备方法和用途
WO2015190573A1 (fr) Composition pour la prévention et/ou l'amélioration de l'anémie ferriprive, et composition pour la prévention et/ou l'amélioration de symptômes indéfinis associés à l'anémie ferriprive
CN104207142A (zh) 一种补锌与排毒营养保健剂的制备方法
HK1159489A (en) Buffered compositions for dialysis

Legal Events

Date Code Title Description
EEER Examination request
H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20250117